38106 Federal Register / Vol. 86, No. 135 / Monday, July 19, 2021 / Notices 

Sum of Both Studies 

Total respondents per year: 72,000. 

Total burden hours per year: 17,160. 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2021–15172 Filed 7–16–21; 8:45 am] 

BILLING CODE 4150–25–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute Of Environmental 

Health Sciences; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel: Mechanism for TimeSensitive Research Opportunities in 

Environmental Health Sciences (R21). 

Date: August 12, 2021. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Environmental 

Health Sciences, Keystone Building, 530 

Davis Drive, Durham, NC 27709 (Virtual 

Meeting). 

Contact Person: Alfonso R. Latoni, Ph.D., 

Chief and Scientific Review Officer, 

Scientific Review Branch, Division of 

Extramural Research and Training, National 

Institute of Environmental Health Sciences, 

Research Triangle Park, NC 27709, 984–287– 

3279, alfonso.latoni@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing, 

National Institutes of Health, HHS) 

Dated: July 14, 2021. 

David W Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–15312 Filed 7–16–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Minority Health 

and Health Disparities: Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Council on Minority Health and Health 

Disparities. 

The meeting will be held as a virtual 

meeting and is open to the public as 

indicated below. Individuals who plan 

to view the virtual meeting and need 

special assistance or other reasonable 

accommodations to view the meeting, 

should notify the Contact Person listed 

below in advance of the meeting. The 

open session will be videocast and can 

be accessed from the NIH Videocasting 

and Podcasting website (http://

videocast.nih.gov/). 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council on Minority Health and Health 

Disparities. 

Date: September 9, 2021. 

Closed: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Name of Committee: National Advisory 

Council on Minority Health and Health 

Disparities. 

Date: September 10, 2021. 

Open: 11:00 a.m. to 4:00 p.m. 

Agenda: Opening Remarks, Administrative 

Matters, Director’s Report, Presentations, and 

Other Business of the Council. 

Place: National Institutes of Health, 6707 

Democracy Boulevard, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Thomas M. Vollberg, Sr., 

Ph.D., Director, Office of Extramural 

Research Administration, National Institute 

on Minority Health and Health Disparities, 

National Institutes of Health, 6707 

Democracy Boulevard, Suite 800, Bethesda, 

Maryland 20892–5465, 301–402–1366, 

Thomas.Vollberg@nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: NIMHD: 

https://www.nimhd.nih.gov/about/advisorycouncil/, where an agenda and any additional 

information for the meeting will be posted 

when available. 

Dated: July 14, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–15311 Filed 7–16–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Instrumentation. 

Date: August 12, 2021. 

Time: 2:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Joonil Seog, SCD Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892, 301–402–9791, 

joonil.seog@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 135 / Monday, July 19, 2021 / Notices 38107 

Dated: July 13, 2021. 

David W Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–15201 Filed 7–16–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) 

will publish periodic summaries of 

proposed projects. To request more 

information on the proposed projects or 

to obtain a copy of the information 

collection plans, call the SAMHSA 

Reports Clearance Officer on (240) 276– 

0361. 

Comments are invited on: (a) Whether 

the proposed collections of information 

are necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Proposed Project: Division of State 

Programs—Management Reporting 

Tool (DSP–MRT) (OMB No. 0930– 

0354)—Revision 

The Substance Abuse and Mental 

Health Services Administration’s 

(SAMHSA) Center for Substance Abuse 

Prevention (CSAP) aims to monitor 

several substance use prevention 

programs through the DSP–MRT, which 

reports data using the Strategic 

Prevention Framework (SPF). Programs 

monitored through the DSP–MRT 

include: SPF-Partnerships for Success 

(PFS), SPF-Prescription Drugs (Rx), 

Prescription Drug Overdose (PDO), and 

First Responder-Comprehensive 

Addiction and Recovery Act (FR– 

CARA). SAMHSA also proposed adding 

a new program: Sober Truth on 

Preventing Underage Drinking Act 

Grants (STOP Act). This request for data 

collection includes a revision from a 

previously approved OMB instrument. 

Monitoring data using the SPF model 

will allow SAMHSA’s project officers to 

systematically collect data to monitor 

their grant program. In addition to 

assessing activities related to the SPF 

steps, the performance monitoring 

instruments covered in this statement 

collect data to assess the following 

grantee required specific performance 

measures: 

• Number of training and technical 

assistance activities per funded 

community provided by the grantee to 

support communities 

• Number of training and technical 

assistance activities (numbers served) 

provided by the grantee 

• Number of subrecipient communities 

that improved on one or more targeted 

National Outcome Measures 

• Number of grantees who integrate 

Prescription Drug Monitoring Program 

(PDMP) data into their program needs 

assessment 

• Number of naloxone toolkits 

distributed 

Changes to this package include the 

following: 

• Inclusion of six performance targets 

• Removal of outdated references 

• Adjustments to the language in the 

Disparities Impact Section to refine 

response. 

ANNUALIZED DATA COLLECTION BURDEN

Instrument Number of 

respondents 

Responses 

per 

respondent 

Total number 

of responses 

Hours per 

response 

Total burden 

hours 

Average 

hourly wage 

Total 

respondent 

cost a

DSP–MRT .................... 521 4 2,084 3 6,252 $44.19 $276,276 

PFS Supplemental ....... 253 1 253 1 253 44.19 11,180 

PDO/FR CARA Supplemental ....................... 109 2 218 1 218 44.19 9,633 

SPF Rx Supplemental 26 4 104 1 104 44.19 4,596 

STOP Act Supplemental (new) ............. 133 1 133 1 133 44.19 5,877 

FY2021–FY2024 Total 521 ........................ ........................ ........................ 6,960 ........................ 307,562 

Send comments to Carlos Graham, 

SAMHSA Reports Clearance Officer, 

5600 Fishers Lane, Room 15E57A, 

Rockville, Maryland 20857, OR email a 

copy to carlos.graham@samhsa.hhs.gov. 

Written comments should be received 

by September 17, 2021. 

Carlos Graham, 

Social Science Analyst. 

[FR Doc. 2021–15293 Filed 7–16–21; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) 

will publish periodic summaries of 

proposed projects. To request more 

information on the proposed projects or 

to obtain a copy of the information 

collection plans, call the SAMHSA 

Reports Clearance Officer at (240) 276– 

0361 or carlos.graham@samhsa.hhs.gov. 

Comments are invited on: (a) Whether 

the proposed collections of information 

are necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) ways to enhance the 


lotter on DSK11XQN23PROD with NOTICES1